Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microcephaly | 2 | 2021 | 331 | 1.040 |
Why?
|
| Phenylbutyrates | 1 | 2023 | 58 | 0.820 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2023 | 77 | 0.800 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 121 | 0.670 |
Why?
|
| Epilepsy | 3 | 2024 | 874 | 0.660 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2021 | 167 | 0.640 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2018 | 12 | 0.590 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2018 | 13 | 0.580 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2017 | 6 | 0.580 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 37 | 0.570 |
Why?
|
| Psychomotor Disorders | 1 | 2017 | 28 | 0.570 |
Why?
|
| Fever of Unknown Origin | 1 | 2018 | 45 | 0.570 |
Why?
|
| Transaminases | 1 | 2017 | 32 | 0.570 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2017 | 37 | 0.570 |
Why?
|
| Seizures | 3 | 2022 | 872 | 0.560 |
Why?
|
| Serine | 1 | 2017 | 175 | 0.540 |
Why?
|
| Students, Medical | 1 | 2021 | 357 | 0.540 |
Why?
|
| Glycine | 1 | 2017 | 168 | 0.530 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 505 | 0.480 |
Why?
|
| Dietary Supplements | 1 | 2017 | 471 | 0.440 |
Why?
|
| Phenotype | 4 | 2024 | 4273 | 0.370 |
Why?
|
| Metabolism, Inborn Errors | 2 | 2022 | 117 | 0.350 |
Why?
|
| Haploinsufficiency | 2 | 2021 | 258 | 0.300 |
Why?
|
| Metabolomics | 3 | 2021 | 423 | 0.290 |
Why?
|
| Developmental Disabilities | 3 | 2024 | 714 | 0.280 |
Why?
|
| Child | 10 | 2024 | 24559 | 0.240 |
Why?
|
| Intellectual Disability | 2 | 2024 | 1056 | 0.240 |
Why?
|
| Failure to Thrive | 1 | 2024 | 90 | 0.220 |
Why?
|
| Acidosis | 1 | 2024 | 93 | 0.210 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2024 | 71 | 0.210 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 140 | 0.200 |
Why?
|
| Epilepsy, Generalized | 1 | 2023 | 64 | 0.200 |
Why?
|
| Transcription Factors | 3 | 2024 | 2604 | 0.190 |
Why?
|
| Ataxia | 1 | 2022 | 170 | 0.180 |
Why?
|
| Schools, Medical | 1 | 2021 | 112 | 0.180 |
Why?
|
| Humans | 20 | 2024 | 125667 | 0.180 |
Why?
|
| Facies | 1 | 2021 | 153 | 0.170 |
Why?
|
| Sudden Infant Death | 1 | 2020 | 32 | 0.170 |
Why?
|
| Citrullinemia | 1 | 2020 | 15 | 0.170 |
Why?
|
| Urinary Tract | 1 | 2020 | 60 | 0.170 |
Why?
|
| Genetic Testing | 2 | 2024 | 1013 | 0.170 |
Why?
|
| Tachycardia, Ventricular | 1 | 2022 | 192 | 0.170 |
Why?
|
| Diagnosis, Differential | 3 | 2024 | 1901 | 0.170 |
Why?
|
| Infant | 5 | 2024 | 12572 | 0.160 |
Why?
|
| Language Development Disorders | 1 | 2021 | 174 | 0.160 |
Why?
|
| Electroencephalography | 1 | 2024 | 866 | 0.160 |
Why?
|
| Exome | 2 | 2024 | 1035 | 0.160 |
Why?
|
| Child, Preschool | 5 | 2024 | 14106 | 0.160 |
Why?
|
| Mutation | 3 | 2023 | 5893 | 0.150 |
Why?
|
| Testis | 1 | 2020 | 411 | 0.150 |
Why?
|
| Mitochondrial Diseases | 1 | 2020 | 132 | 0.150 |
Why?
|
| Male | 11 | 2024 | 61776 | 0.140 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 651 | 0.140 |
Why?
|
| Heart Arrest | 1 | 2022 | 356 | 0.140 |
Why?
|
| Genomics | 2 | 2024 | 1516 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 460 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 501 | 0.140 |
Why?
|
| Curriculum | 1 | 2021 | 727 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2020 | 480 | 0.130 |
Why?
|
| Mass Screening | 1 | 2021 | 787 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 440 | 0.120 |
Why?
|
| Abnormalities, Multiple | 1 | 2021 | 960 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2020 | 1030 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 1273 | 0.110 |
Why?
|
| Young Adult | 3 | 2024 | 9093 | 0.110 |
Why?
|
| Adolescent | 5 | 2024 | 19441 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2020 | 1504 | 0.110 |
Why?
|
| Female | 9 | 2024 | 66998 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1533 | 0.090 |
Why?
|
| Lung | 1 | 2018 | 1496 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1912 | 0.080 |
Why?
|
| Adult | 4 | 2024 | 29734 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2023 | 16417 | 0.070 |
Why?
|
| Neurons | 1 | 2017 | 1940 | 0.070 |
Why?
|
| Middle Aged | 3 | 2024 | 27000 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2020 | 8249 | 0.070 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 90 | 0.050 |
Why?
|
| 4-Aminopyridine | 1 | 2023 | 32 | 0.050 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2023 | 40 | 0.050 |
Why?
|
| Mammals | 1 | 2024 | 258 | 0.050 |
Why?
|
| Diarrhea | 1 | 2024 | 318 | 0.050 |
Why?
|
| Verapamil | 1 | 2022 | 55 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2023 | 107 | 0.050 |
Why?
|
| Isoproterenol | 1 | 2022 | 106 | 0.050 |
Why?
|
| Magnesium | 1 | 2022 | 123 | 0.050 |
Why?
|
| Amish | 1 | 2020 | 8 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 224 | 0.040 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2020 | 30 | 0.040 |
Why?
|
| Ammonia | 1 | 2020 | 75 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2022 | 348 | 0.040 |
Why?
|
| Hypothermia | 1 | 2020 | 57 | 0.040 |
Why?
|
| Drosophila | 1 | 2024 | 776 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2024 | 878 | 0.040 |
Why?
|
| Diet, Protein-Restricted | 1 | 2020 | 81 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 608 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 460 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2019 | 658 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2022 | 688 | 0.040 |
Why?
|
| Arginine | 1 | 2020 | 336 | 0.040 |
Why?
|
| Diet | 1 | 2022 | 1140 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2714 | 0.030 |
Why?
|
| Aged | 2 | 2024 | 19900 | 0.030 |
Why?
|
| Kidney | 1 | 2020 | 1369 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3439 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4690 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7223 | 0.020 |
Why?
|
| Animals | 1 | 2024 | 34349 | 0.010 |
Why?
|